ACIP
alert icon
COVID-19 Vaccination Recommendations
Find the latest ACIP recommendations for COVID-19 vaccination.
Webcast
May 5, 2021 meeting is a virtual meeting.
No registration is required.
Final Agenda – May 5, 2021pdf icon
May 12, 2021 emergency meeting is a virtual meeting.
No registration is required.
Contact ACIP Secretariat
1600 Clifton Road, N.E., Mailstop H24-8
Atlanta, GA 30329-4027
acip@cdc.gov
email_03Get Email Updates
To receive email updates about this page, enter your email address:
February 2021 Meeting Recommendations
ACIP approved the following recommendations by majority vote at its February 24-25, 2021 meeting.
- ACIP recommends a 2-dose [0, 7 days] intramuscular rabies vaccine series in immunocompetent persons ≥18 years of age for whom rabies vaccine pre-exposure prophylaxis (PrEP) is indicated.
- ACIP recommends an intramuscular booster dose of rabies vaccine, as an alternative to a titer check, for immunocompetent persons ≥18 years of age who have sustained and elevated risk for only recognized rabies exposures (i.e., those in risk category #3 of rabies PrEP recommendations table). The booster dose should be administered no sooner than day 21 but no later than 3 years after the 2-dose PrEP series.
These recommendations have been adopted by the CDC Director and will become official once published in MMWR.
Page last reviewed: May 4, 2021
Content source: National Center for Immunization and Respiratory Diseases






